Clarity Pharmaceuticals Ltd

ASX:CU6 (Australia)  
A$ 4.35 (+5.33%) May 24
At Loss
P/B:
10.43
Market Cap:
A$ 1.35B ($ 896.30M)
Enterprise V:
A$ 1.31B ($ 871.14M)
Volume:
1.77M
Avg Vol (2M):
1.14M
Also Trade In:
Volume:
1.77M
At Loss
Avg Vol (2M):
1.14M

Business Description

Description
Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company developing next-generation theranostic (therapy and imaging) products, based on its platform SAR Technology. The SAR technology is ideally suited for use with copper isotopes, enabling superior imaging and therapeutic characteristics of radiopharmaceutical products and addressing the current manufacturing and logistical limitations in the growth of the radiopharmaceutical sector in oncology.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.91
Interest Coverage No Debt
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 75.3
9-Day RSI 74.04
14-Day RSI 73.13
6-1 Month Momentum % 102.96
12-1 Month Momentum % 245.44

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 11.76
Quick Ratio 11.76
Cash Ratio 7.76

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -44.94
ROA % -40.79
ROIC % -451.22
ROC (Joel Greenblatt) % -589.8
ROCE % -61.92

Financials

ASX:CU6's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Clarity Pharmaceuticals Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$)
EPS (TTM) (A$) -0.118
Beta 0
Volatility % 57.27
14-Day RSI 73.13
14-Day ATR (A$) 0.191181
20-Day SMA (A$) 3.7675
12-1 Month Momentum % 245.44
52-Week Range (A$) 0.67291 - 4.35
Shares Outstanding (Mil) 311.01

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Clarity Pharmaceuticals Ltd Filings

Filing Date Document Date Form
No Filing Data

Clarity Pharmaceuticals Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Clarity Pharmaceuticals Ltd Frequently Asked Questions

What is Clarity Pharmaceuticals Ltd(ASX:CU6)'s stock price today?
The current price of ASX:CU6 is A$4.35. The 52 week high of ASX:CU6 is A$4.35 and 52 week low is A$0.67.
When is next earnings date of Clarity Pharmaceuticals Ltd(ASX:CU6)?
The next earnings date of Clarity Pharmaceuticals Ltd(ASX:CU6) is .
Does Clarity Pharmaceuticals Ltd(ASX:CU6) pay dividends? If so, how much?
Clarity Pharmaceuticals Ltd(ASX:CU6) does not pay dividend.

Press Release

Subject Date
No Press Release